Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms

Antitumour activity of docetaxel (Taxotere®) in hormone-dependent (HD) and hormone-independent (HID) prostate cancer PAC120 xenograft model was previously reported, and its level was associated with HER2 protein expression. In the present study, we evaluate the antitumour effects of docetaxel combin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Legrier, M-E, Oudard, S, Judde, J-G, Guyader, C, de Pinieux, G, Boyé, K, de Cremoux, P, Dutrillaux, B, Poupon, M-F
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2007
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2359985/
https://ncbi.nlm.nih.gov/pubmed/17211467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603553
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados